{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T19:46:36Z","timestamp":1780947996601,"version":"3.54.1"},"reference-count":29,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T00:00:00Z","timestamp":1688256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Scho 402\/12-2"],"award-info":[{"award-number":["Scho 402\/12-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>The purine derivative fludarabine is part of frontline therapy for chronic lymphocytic leukaemia (CLL). It has shown positive effects on solid tumours such as melanoma, breast, and colon carcinoma in clinical phase I studies. As the treatment of CLL cells with combinations of fludarabine and metal complexes of antitumoural natural products, e.g., illudin M ferrocene, has led to synergistically enhanced apoptosis, in this research study different complexes of fludarabine itself. Four complexes bearing a trans-[Br(PPh3)2]Pt\/Pd fragment attached to atom C-8 via formal \u03b71-sigma or \u03b72-carbene bonds were synthesised in two or three steps without protecting polar groups on the arabinose or adenine. The platinum complexes were more cytotoxic than their palladium analogues, with low single-digit micromolar IC50 values against cells of various solid tumour entities, including cisplatin-resistant ones and certain B-cell lymphoma and CLL, presumably due to the ten-fold higher cellular uptake of the platinum complexes. However, the palladium complexes interacted more readily with isolated Calf thymus DNA. Interestingly, the platinum complexes showed vastly greater selectivity for cancer over non-malignant cells when compared with fludarabine.<\/jats:p>","DOI":"10.3390\/molecules28135173","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:53:16Z","timestamp":1688345596000},"page":"5173","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Palladium and Platinum Complexes of the Antimetabolite Fludarabine with Vastly Enhanced Selectivity for Tumour over Non-Malignant Cells"],"prefix":"10.3390","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5614-773X","authenticated-orcid":false,"given":"Sebastian W.","family":"Schleser","sequence":"first","affiliation":[{"name":"Organic Chemistry Laboratory, University Bayreuth, Universitaetsstrasse 30, 95447 Bayreuth, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksandr","family":"Krytovych","sequence":"additional","affiliation":[{"name":"Organic Chemistry Laboratory, University Bayreuth, Universitaetsstrasse 30, 95447 Bayreuth, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Ziegelmeier","sequence":"additional","affiliation":[{"name":"Organic Chemistry Laboratory, University Bayreuth, Universitaetsstrasse 30, 95447 Bayreuth, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1506-9559","authenticated-orcid":false,"given":"Elisabeth","family":"Gro\u00df","sequence":"additional","affiliation":[{"name":"University Clinic for Internal Medicine IV, Hematology\/Oncology, Medical Faculty, Martin Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5279-5381","authenticated-orcid":false,"given":"Jana","family":"Kasparkova","sequence":"additional","affiliation":[{"name":"Department of Biophysics, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8233-1393","authenticated-orcid":false,"given":"Viktor","family":"Brabec","sequence":"additional","affiliation":[{"name":"Department of Biophysics, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8724-9348","authenticated-orcid":false,"given":"Thomas","family":"Weber","sequence":"additional","affiliation":[{"name":"University Clinic for Internal Medicine IV, Hematology\/Oncology, Medical Faculty, Martin Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8413-4342","authenticated-orcid":false,"given":"Rainer","family":"Schobert","sequence":"additional","affiliation":[{"name":"Organic Chemistry Laboratory, University Bayreuth, Universitaetsstrasse 30, 95447 Bayreuth, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4637-0157","authenticated-orcid":false,"given":"Thomas","family":"Mueller","sequence":"additional","affiliation":[{"name":"University Clinic for Internal Medicine IV, Hematology\/Oncology, Medical Faculty, Martin Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: An overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_2","first-page":"000569","article-title":"Prevalence of different types of leukemia and associated factors among children with leukemia in children\u2019s cancer units at Al-Kuwait Hospital, Sana\u2019a City: A cross-sectional study","volume":"3","author":"Alhadi","year":"2021","journal-title":"Glob. J. Ped. Neonatol. Car."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1056\/NEJMra1908213","article-title":"Treatment of chronic lymphocytic leukemia","volume":"383","author":"Burger","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.annonc.2020.09.019","article-title":"Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Eichhorst","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"33124","DOI":"10.18632\/oncotarget.26043","article-title":"Fludarabine-resistance associates with ceramide metabolism and leukemia stem cell development in chronic lymphocytic leukemia","volume":"9","author":"Huang","year":"2018","journal-title":"Oncotarget"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0140-6736(10)61381-5","article-title":"Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukemia: A randomised, open-label, phase 3 trial","volume":"376","author":"Hallek","year":"2010","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Cheson, B.D., Keating, M.J., and Plunkett, W. (2021). Nucleoside Analogs in Cancer Therapy, CRC Press.","DOI":"10.1201\/9781003067634"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00003088-200241020-00002","article-title":"Cellular and clinical pharmacology of fludarabine","volume":"41","author":"Gandhi","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"16617","DOI":"10.1016\/S0021-9258(17)46267-3","article-title":"Termination of DNA synthesis by 9-beta-d-arabinosyl-2-fluoroadenine. A mechanism for cytotoxicity","volume":"265","author":"Huang","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_10","first-page":"3","article-title":"Metabolism and action of fludarabine phosphate","volume":"17","author":"Plunkett","year":"1990","journal-title":"Semin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/sj.leu.2401845","article-title":"Inhibition of RNA transcription: A biochemical mechanism of action against chrocic lymphocytic leukemia cells by fludarabine","volume":"14","author":"Huang","year":"2000","journal-title":"Leukemia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/15257770.2013.863334","article-title":"Mechanism of action of fludarabine nucleoside against human Raji lymphoma cells","volume":"33","author":"Christopherson","year":"2014","journal-title":"Nucleos. Nucleot Nucl."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12185-011-0930-8","article-title":"Synergistic effects of combination with fludarabine and carboplatin depend on fludarabine-mediated inhibition of enhanced nucleotide excision repair in leukemia","volume":"94","author":"Takagi","year":"2011","journal-title":"Int. J. Hematol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1158\/1078-0432.CCR-10-2561","article-title":"Killing of chronic lymphocytic leukemia by the combination of fludarabine and oxaliplatin is dependent on the activity of XPF endonuclease","volume":"17","author":"Zecevic","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1182\/blood-2006-05-023259","article-title":"Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removal","volume":"108","author":"Moufarij","year":"2006","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/leu.2016.294","article-title":"Targeting transcription-coupled nucleotide excision repair overcomes resistance in chronic lymphocytic leukemia","volume":"31","author":"Lohmann","year":"2017","journal-title":"Leukemia"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7588","DOI":"10.1039\/b905798f","article-title":"A categorization of metal anticancer compounds based on their mode of action","volume":"37","author":"Gianferrara","year":"2009","journal-title":"Dalton Trans."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1002\/chem.202005451","article-title":"Guided antitumoral drugs: (imidazol-2-ylidene)(L)gold(I) complexes seeking cellular targets controlled by the nature of ligand L","volume":"27","author":"Gold","year":"2021","journal-title":"Chem. Eur. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2533\/chimia.2007.716","article-title":"Ferrocifens and ferrocifenols as new potential weapons against breast cancer","volume":"61","author":"Nguyen","year":"2007","journal-title":"Chimia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/CAD.0b013e32832e056a","article-title":"Melanoma specific ferrocene esters of the fungal cytotoxin illudin M","volume":"20","author":"Knauer","year":"2009","journal-title":"Anticancer Drugs"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00775-022-01968-x","article-title":"Revisiting the anticancer properties of phosphane(9-ribosylpurine-6-thiolato)gold(I) complexes and their 9H-purine precursors","volume":"27","author":"Kober","year":"2022","journal-title":"J. Biol. Inorg. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"15653","DOI":"10.1021\/acsomega.8b02387","article-title":"N-heterocyclic carbenes derived from guanosine: Synthesis and evidences of their antiproliferative activity","volume":"3","author":"Herrera","year":"2018","journal-title":"ACS Omega"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1021\/acs.organomet.8b00685","article-title":"Selective C8-metalation of purine nucleosides via oxidative addition","volume":"37","author":"Kampert","year":"2018","journal-title":"Organometallics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1021\/om0500220","article-title":"Mechanistic pathways for oxidative addition of aryl halides to palladium(0) complexes: A DFT study","volume":"24","author":"Goossen","year":"2005","journal-title":"Organometallics"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1021\/om980283s","article-title":"A novel reversible aryl exchange involving two organometallics:\u2009mechanism of the gold(I)-catalyzed isomerization of trans-[PdR2L2] complexes (R = aryl, L = SC4H8)","volume":"17","author":"Casado","year":"1998","journal-title":"Organometallics"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Leit\u00e3o, M.I.P.S., Francescato, G., Gomes, C.S.B., and Petronilho, A. (2021). Synthesis of platinum(II) N-heterocyclic carbenes based on adenosine. Molecules, 26.","DOI":"10.3390\/molecules26175384"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.17344\/acsi.2019.5196","article-title":"Design, synthesis and in vitro cytotoxic activity of new 6,9-disubstituted purine analogues","volume":"67","author":"Kucukdumlu","year":"2020","journal-title":"Acta Chim. Slov."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1039\/C4CS00063C","article-title":"Anti-cancer palladium complexes: A focus on PdX2L2, palladacycles and related complexes","volume":"43","author":"Kapdi","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1158\/1535-7163.MCT-15-0824","article-title":"Improved tumor-specific drug accumulation by polymer therapeutics with pH-sensitive drug release overcomes chemotherapy resistance","volume":"15","author":"Heinrich","year":"2016","journal-title":"Mol. Cancer Ther."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/13\/5173\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:04:57Z","timestamp":1760126697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/13\/5173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,2]]},"references-count":29,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["molecules28135173"],"URL":"https:\/\/doi.org\/10.3390\/molecules28135173","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,2]]}}}